These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19306748)

  • 1. Does incidental irradiation with doses below 50 gy effectively reduce isolated nodal failures in non-small-cell lung cancer: dose-response relationship.
    Kepka L; Maciejewski B; Withers RH
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1391-6. PubMed ID: 19306748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental irradiation of mediastinal and hilar lymph node stations during 3D-conformal radiotherapy for non-small cell lung cancer.
    Kepka L; Bujko K; Zolciak-Siwinska A; Garmol D
    Acta Oncol; 2008; 47(5):954-61. PubMed ID: 17899455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?
    Chen M; Hayman JA; Ten Haken RK; Tatro D; Fernando S; Kong FM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):120-6. PubMed ID: 16198503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located.
    Zhao L; Chen M; Ten Haken R; Chetty I; Chapet O; Hayman JA; Kong FM
    Radiother Oncol; 2007 Feb; 82(2):153-9. PubMed ID: 17287040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.
    Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses.
    Sanuki-Fujimoto N; Sumi M; Ito Y; Imai A; Kagami Y; Sekine I; Kunitoh H; Ohe Y; Tamura T; Ikeda H
    Radiother Oncol; 2009 Jun; 91(3):433-7. PubMed ID: 19167118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques--a retrospective analysis.
    Kepka L; Bujko K; Zolciak-Siwinska A
    Acta Oncol; 2008; 47(1):95-103. PubMed ID: 17851862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involved-field three-dimensional conformal radiation treatment for stage III non-small-cell lung].
    Yu JM; Sun XD; Li MH; Zhang JD; Yao CP; Liu S; Zhang Z
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):526-9. PubMed ID: 17147119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involved-field radiation therapy for inoperable non small-cell lung cancer.
    Rosenzweig KE; Sura S; Jackson A; Yorke E
    J Clin Oncol; 2007 Dec; 25(35):5557-61. PubMed ID: 17984185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.
    De Ruysscher D; Bremer RH; Koppe F; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Pitz C; Simons J; ten Velde G; Dohmen J; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Dehing C; Pijls M; Minken A; Lambin P
    Radiother Oncol; 2006 Sep; 80(3):307-12. PubMed ID: 16949169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
    Giraud P; De Rycke Y; Lavole A; Milleron B; Cosset JM; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):127-35. PubMed ID: 16226394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.
    Yuan S; Sun X; Li M; Yu J; Ren R; Yu Y; Li J; Liu X; Wang R; Li B; Kong L; Yin Y
    Am J Clin Oncol; 2007 Jun; 30(3):239-44. PubMed ID: 17551299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of incidental mediastinal and hilar irradiation delivered during definitive stereotactic body radiation therapy for peripheral non-small cell lung cancer.
    Martin KL; Gomez J; Nazareth DP; Warren GW; Singh AK
    Med Dosim; 2012; 37(2):182-5. PubMed ID: 21978531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?
    Jeremic B
    Radiother Oncol; 2004 May; 71(2):123-5. PubMed ID: 15110444
    [No Abstract]   [Full Text] [Related]  

  • 17. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.
    Fernandes AT; Shen J; Finlay J; Mitra N; Evans T; Stevenson J; Langer C; Lin L; Hahn S; Glatstein E; Rengan R
    Radiother Oncol; 2010 May; 95(2):178-84. PubMed ID: 20356642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of incidental irradiation on clinically uninvolved nodal regions in patients with advanced non-small-cell lung cancer treated with involved-field radiation therapy: does incidental irradiation contribute to the low incidence of elective nodal failure?
    Kimura T; Togami T; Nishiyama Y; Ohkawa M; Takashima H
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):337-43. PubMed ID: 19775827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.